Revenue from operations rose to Rs 675.9 crore for the period under review as compared with Rs 593.49 crore in the same period of 2020-21 fiscal, Pfizer Ltd said in a regulatory filing.from Stocks-Markets-Economic Times
Read The Rest:economictimes...
